Generic Name: Daclizumab beta
Brand Name: Zinbryta
Manufacturer: Biogen Canada Inc.
Indications: Multiple Sclerosis, relapsing
Submission Type: New
Project Status: Complete
Date Recommendation Issued: June 20, 2017
Recommendation Type: Reimburse with clinical criteria and/or conditions